Meningococcal Disease Information for Travelers
Meningitis poses a serious risk to travelers, especially those visiting Saudi Arabia or the sub-Saharan "meningitis belt." Vaccination is essential protection and is required for entry to Saudi Arabia.
What Is Meningococcal Disease?
Meningococcal disease is a serious bacterial infection caused by Neisseria meningitidis. It is a life-threatening emergency that attacks the meninges (membranes surrounding the brain and spinal cord), causing meningitis. The disease can progress rapidly and cause death within hours if untreated.
How It Is Transmitted
Meningococcal disease is transmitted through respiratory droplets from the nasopharynx (throat) of infected individuals. Transmission occurs through coughing, sneezing, and close contact. The bacteria can also be spread through saliva sharing (sharing drinks, eating utensils, etc.). Crowded living conditions and close contact dramatically increase transmission risk.
Serogroups Relevant to Travelers
- Serogroup A: Endemic in the sub-Saharan "meningitis belt" (Dec-June dry season)
- Serogroup C: Causes outbreaks in developed countries and parts of Africa
- Serogroup W: Increasing incidence globally, especially in Saudi Arabia and large gatherings
- Serogroup Y: Occurs in North America and other developed regions
- Serogroup B: Covered by a separate vaccine; causes sporadic disease in developed countries
Clinical Presentation
Meningitis symptoms develop rapidly and constitute a medical emergency. Classic symptoms include sudden high fever (104-105°F), severe headache, stiff neck (nuchal rigidity), sensitivity to light (photophobia), rash (petechial or purpuric), nausea, vomiting, altered mental status, and confusion. The rash is non-blanching and indicates bacteremia.
Severity and Outcomes
- Mortality: 10-15% fatality rate even with treatment
- Morbidity: 15-30% of survivors experience permanent complications including hearing loss, neurological disability, and limb amputation
- Severity: Can progress from symptom onset to severe illness within hours
Who Is at Risk?
Meningococcal disease risk is highest in specific regions and situations:
High-Risk Regions
"Meningitis Belt" (Sub-Saharan Africa)
West and Central Africa (Dec-June dry season) — serogroup A endemic
Saudi Arabia
Required for entry; serogroups A, W, C circulate in large gatherings
Other Risk Areas
Crowded living conditions globally (military, university dormitories)
Higher-Risk Travelers
- • Travelers to Saudi Arabia (REQUIRED for entry)
- • Travelers to sub-Saharan Africa (Dec-June)
- • Travelers in close quarters (student dormitories, military barracks)
- • Healthcare workers in endemic areas
- • People with certain medical conditions (complement deficiency)
- • Those staying with local families in endemic areas
How to Prevent Meningococcal Disease
1. Meningococcal Vaccination (ACYW-135)
Meningococcal vaccination (ACYW-135) is the most important prevention tool for travelers. It is required for entry to Saudi Arabia and is recommended for all travelers to high-risk regions. Peel Travel Clinic provides the recommended ACYW-135 vaccine.
Vaccines: Menquadfi or Menveo (ACYW-135 conjugate vaccines)
Dose: Single intramuscular injection
Protection: Begins within 2 weeks; provides at least 5 years protection
Saudi Arabia Requirement: Must be administered 10 days to 3 years before travel
2. Meningitis B Vaccination
Serogroup B requires a separate vaccine (Bexsero or Neis Vac-4). Consider this vaccine if you are a young adult traveling to crowded settings or have risk factors. Our physician will assess if Meningitis B vaccination is appropriate for you.
3. Respiratory Hygiene and Avoiding Close Contact
- • Avoid crowded indoor spaces when possible, especially in endemic areas during high-transmission seasons
- • Practice good respiratory hygiene (cover coughs/sneezes)
- • Avoid sharing eating utensils, drinks, or personal items
- • Maintain good hand hygiene
- • Ensure adequate rest and nutrition to maintain immunity
4. High-Risk Timing Considerations
If traveling to the sub-Saharan "meningitis belt," consider timing your travel outside the dry season (December-June) when serogroup A transmission is highest. If travel during this period is unavoidable, vaccination is essential.
Our Meningitis Vaccination Service
Peel Travel Clinic provides meningococcal vaccination for all travelers, with special attention to those traveling to Saudi Arabia and sub-Saharan Africa. We ensure compliance with Saudi Arabia's vaccination requirements and provide personalized recommendations for all high-risk travelers.
Our Service Includes:
- • Risk assessment based on destination and duration of travel
- • ACYW-135 vaccination (Menquadfi or Menveo)
- • Assessment for additional Meningitis B vaccination if indicated
- • Verification of vaccination compliance for Saudi Arabia entry
- • Documentation and vaccination records
- • Guidance on respiratory hygiene and close-contact avoidance
Important for Saudi Arabia Travelers:
Saudi Arabia REQUIRES meningococcal vaccination (ACYW-135) for entry. The vaccination must be administered 10 days to 3 years before travel. Plan your vaccination appointment well in advance of your trip.
40+
Years of Clinical Experience
ISTM
Travel Medicine Society Member
CAME
Transport Canada Designated
YF Centre
Yellow Fever Designated Centre
550 Matheson Blvd W, Unit 107, Mississauga, Ontario L5R 4B8 · (905) 890-2757
Protect Yourself Before You Travel
Disclaimer: Vaccine requirements and health recommendations vary by itinerary, medical history, and current health advisories. The information on this page is for general guidance only and does not replace a personalized travel health consultation. Please book an appointment with our physician for advice specific to your trip.